Loss Ratio (Annual)

Loss Ratio: A measure of profitability used by an insurance company to indicate how well it is performing in its daily operations. The loss ratio is calculated by taking the incurred underwriting losses and then dividing them by earned premium. Calculated as: Underwriting Losses Total / Net Premiums Earned

Verrica Pharmaceuticals Inc. (VRCA) Loss Ratio data is not available.

Quarterly Annual

Figures for fiscal year ending 2024-12-31

Income Statement Financials
Revenue	$7.57M
Net Income	$-76.58M
Cost of Goods Sold	$2.74M
Gross Profit	$4.83M
Operating Expenses	$73.48M
Operating Income	$-65.92M
Non-Operating Income/Expense	$-10.66M
Pre-Tax Income	$-76.58M
Normalized Pre-Tax Income	$-76.58M
Income after Taxes	$-76.58M
Income from Continuous Operations	$-76.58M
Consolidated Net Income/Loss	$-76.58M
Normalized Income after Taxes	$-76.58M
EBIT	$-65.92M
EBITDA	$-64.65M
Weighted-Average Shares Outstanding (Basic)	51.81M
Weighted-Average Shares Outstanding (Diluted)	51.81M
Earnings per Share (EPS) (Basic)	$-1.48
Earnings per Share (EPS) (Diluted)	$-1.48
Balance Sheet Financials
Current Assets	$51.18M
Property, Plant, and Equipment	$0.59M
Long-Term Assets	$2.96M
Total Assets	$54.13M
Current Liabilities	$29.01M
Long-Term Debt	$31.75M
Long-Term Liabilities	$34.98M
Total Liabilities	$63.99M
Common Equity	$-9.86M
Tangible Shareholders Equity	$-9.86M
Shareholders Equity	$-9.86M
Common Shares Outstanding	91.78M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-60.93M
Cash Flow from Investing Activities	$-0.02M
Cash Flow from Financial Activities	$37.73M
Beginning Cash	$69.55M
End Cash	$46.33M
Increase/Decrease in Cash	$-23.22M
Stock-Based Compensation	$7.16M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.76
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	1.45
Debt to Equity Ratio	-4.57
Gross Margin	63.79%
Operating Margin	-871.25%
EBIT Margin	-871.25%
EBITDA Margin	-854.48%
Pre-Tax Profit Margin	-1012.15%
Profit Margin	-1012.15%
Free Cash Flow	$-60.95M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.14
Inventory Turnover	1.11
Receiveable Turnover	98.26
Days Sales in Receivables	3.71
Return on Equity	776.66%
Return on Tangible Equity	776.66%
Return on Assets	-141.46%
Return on Investments	-349.82%
Book Value Per Share	$-0.11
Free Cash Flow per Share	$-1.18
Operating Cash Flow per Share	$-1.18

Data from Zacks Investment Research, Inc.